Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fry

Showing results (671-680 of 737) with videos related to

Pageof 74
Sort By:
Radiology|March 3, 2009
Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunitySergio A Dromi, Meghaan P Walsh, Sarah Herby, et al.
Frontiers in Immunology|September 7, 2021
Combining Immunocytokine and <i>Ex Vivo</i> Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2<sup>+</sup> Murine NeuroblastomaPaul D Bates, Alexander L Rakhmilevich, Monica M Cho, et al.
Blood Advances|August 8, 2019
Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapyNirali N Shah, Haiying Qin, Bonnie Yates, et al.
Cancer Research|May 29, 2025
CARM1-Mediated MAP2K4 Methylation Potentiates the Oncogenic Functions of MAP2K4 and Constitutes a Targetable Dependency in Triple-Negative Breast CancerEui-Jun Kim, Yidan Wang, Yu-Lin Chen, et al.
The Journal of Biological Chemistry|July 1, 2018
Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9Tewfik Hamidi, Anup Kumar Singh, Nicolas Veland, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell TherapyHaneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Molecular Therapy. Methods & Clinical Development|March 20, 2018
A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical TrialsHenrieta Fraser, Niloufar Safinia, Nathali Grageda, et al.
Molecular Therapy. Advances|May 18, 2026
A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cellsYilong Yang, Saurabh Parikh, Chieh-Yuan Li, et al.
Leukemia|December 16, 2024
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemiaTommaso Balestra, Lisa M Niswander, Asen Bagashev, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cellsSteven A Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, et al.
Pageof 74

Showing results (671-680 of 737) with videos related to

Sort By:
Pageof 74
Radiology|March 3, 2009
Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunitySergio A Dromi, Meghaan P Walsh, Sarah Herby, et al.
Frontiers in Immunology|September 7, 2021
Combining Immunocytokine and <i>Ex Vivo</i> Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2<sup>+</sup> Murine NeuroblastomaPaul D Bates, Alexander L Rakhmilevich, Monica M Cho, et al.
Blood Advances|August 8, 2019
Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapyNirali N Shah, Haiying Qin, Bonnie Yates, et al.
Cancer Research|May 29, 2025
CARM1-Mediated MAP2K4 Methylation Potentiates the Oncogenic Functions of MAP2K4 and Constitutes a Targetable Dependency in Triple-Negative Breast CancerEui-Jun Kim, Yidan Wang, Yu-Lin Chen, et al.
The Journal of Biological Chemistry|July 1, 2018
Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9Tewfik Hamidi, Anup Kumar Singh, Nicolas Veland, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell TherapyHaneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Molecular Therapy. Methods & Clinical Development|March 20, 2018
A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical TrialsHenrieta Fraser, Niloufar Safinia, Nathali Grageda, et al.
Molecular Therapy. Advances|May 18, 2026
A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cellsYilong Yang, Saurabh Parikh, Chieh-Yuan Li, et al.
Leukemia|December 16, 2024
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemiaTommaso Balestra, Lisa M Niswander, Asen Bagashev, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cellsSteven A Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, et al.
Pageof 74